SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-12-13 14:05
Tx date 2021-12-08
$APLI
Appili Therapeutics Inc.
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$31,850
+245,000 vol
$0.13 each
525,000
Filed 2021-12-13 14:02
Tx date 2021-12-08
$APLI
Appili Therapeutics Inc.
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$31,850
+245,000 vol
$0.13 each
665,000
Filed 2021-12-13 14:01
Tx date 2021-12-08
$APLI
Appili Therapeutics Inc.
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$31,850
+245,000 vol
$0.13 each
710,000
Filed 2021-12-13 13:57
Tx date 2021-12-08
$APLI
Appili Therapeutics Inc.
Mortimer, Ian Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$31,850
+245,000 vol
$0.13 each
710,000
Filed 2021-12-13 13:55
Tx date 2021-12-08
$APLI
Appili Therapeutics Inc.
Cilla, Donald
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$45,500
+350,000 vol
$0.13 each
750,000
Filed 2021-12-13 13:53
Tx date 2021-12-08
$APLI
Appili Therapeutics Inc.
Golan, Yoav
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$26,000
+200,000 vol
$0.13 each
600,000
Filed 2021-12-10 20:12
Tx date 2021-12-08
$APLI
Appili Therapeutics Inc.
Howling, Kenneth George
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$19,500
+150,000 vol
$0.13 each
350,000
Filed 2021-11-29 16:42
Tx date 2021-11-29
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-35,935.80
-237,200 vol
$0.1515 each
5,301,101
Filed 2021-11-19 16:10
Tx date 2021-11-16
$APLI
Appili Therapeutics Inc.
Howling, Kenneth George
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
200,000
Filed 2021-11-19 16:08
Tx date 2021-11-15
$APLI
Appili Therapeutics Inc.
Howling, Kenneth George
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-18 10:34
Tx date 2021-10-15
$APLI
Appili Therapeutics Inc.
Vejvoda, Josef
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+140,000 vol
140,000
Filed 2021-10-18 10:28
Tx date 2021-09-07
$APLI
Appili Therapeutics Inc.
Vejvoda, Josef
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-14 14:02
Tx date 2021-10-14
$APLI
Appili Therapeutics Inc.
Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
46 - Compensation for services

+128,674 vol
665,996
Filed 2021-10-14 14:00
Tx date 2021-10-14
$APLI
Appili Therapeutics Inc.
Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
46 - Compensation for services

+128,674 vol
665,996
Filed 2021-09-07 14:51
Tx date 2021-09-07
$APLI
Appili Therapeutics Inc.
Vejvoda, Josef
4 - Director of Issuer
Direct Ownership
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-07-09 17:52
Tx date 2021-07-08
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$330.00
+500 vol
$0.66 each
5,538,301
Filed 2021-07-02 16:50
Tx date 2021-06-30
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$640.00
+1,000 vol
$0.64 each
5,537,801
Filed 2021-06-25 16:42
Tx date 2021-06-21
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$26,050
+36,500 vol
$0.71 each
5,536,801
Filed 2021-06-18 17:00
Tx date 2021-06-15
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$26,491
+35,000 vol
$0.76 each
5,500,301
Filed 2021-05-21 16:53
Tx date 2021-05-19
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$33,519
+39,500 vol
$0.85 each
5,465,301
Filed 2021-05-21 16:53
Tx date 2021-05-18
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$88,000
+100,000 vol
$0.88 each
5,425,801
Filed 2021-05-09 11:57
Tx date 2021-05-07
$APLI
Appili Therapeutics Inc.
Balboni, Armand
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
1,718,000
Filed 2021-05-08 13:10
Tx date 2021-05-07
$APLI
Appili Therapeutics Inc.
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$170,800
+140,000 vol
$1.22 each
280,000
Filed 2021-05-08 13:04
Tx date 2021-05-07
$APLI
Appili Therapeutics Inc.
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$170,800
+140,000 vol
$1.22 each
420,000
Filed 2021-05-08 13:00
Tx date 2021-05-07
$APLI
Appili Therapeutics Inc.
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$170,800
+140,000 vol
$1.22 each
465,000
Filed 2021-05-08 12:57
Tx date 2021-05-07
$APLI
Appili Therapeutics Inc.
Mortimer, Ian Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$170,800
+140,000 vol
$1.22 each
465,000
Filed 2021-05-08 12:52
Tx date 2021-05-07
$APLI
Appili Therapeutics Inc.
Stephens, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$366,000
+300,000 vol
$1.22 each
710,000
Filed 2021-05-08 12:45
Tx date 2021-05-07
$APLI
Appili Therapeutics Inc.
Cilla, Donald
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$244,000
+200,000 vol
$1.22 each
400,000
Filed 2021-05-08 12:41
Tx date 2021-05-07
$APLI
Appili Therapeutics Inc.
Golan, Yoav
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$244,000
+200,000 vol
$1.22 each
400,000
Filed 2021-03-06 10:11
Tx date 2021-03-04
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$6,546
+6,500 vol
$1.01 each
5,325,801
Filed 2021-03-06 10:11
Tx date 2021-03-03
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$4,935
+4,700 vol
$1.05 each
5,319,301
Filed 2021-03-06 10:11
Tx date 2021-03-01
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-550.00
-500 vol
$1.10 each
5,314,601
Filed 2021-02-26 17:05
Tx date 2021-02-26
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$4,180
+4,000 vol
$1.04 each
5,315,101
Filed 2021-02-26 17:04
Tx date 2021-02-23
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$44,339
+41,300 vol
$1.07 each
5,311,101
Filed 2021-02-26 17:04
Tx date 2021-02-22
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$38,083
+34,300 vol
$1.11 each
5,269,801
Filed 2021-02-19 17:07
Tx date 2021-02-18
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-58,892.33
-46,900 vol
$1.26 each
5,235,501
Filed 2021-02-19 17:06
Tx date 2021-02-17
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-101,880.90
-75,300 vol
$1.35 each
5,282,401
Filed 2021-02-19 17:06
Tx date 2021-02-16
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-111,237.30
-83,700 vol
$1.33 each
5,357,701
Filed 2021-02-12 18:57
Tx date 2021-02-12
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-21,120.84
-15,600 vol
$1.35 each
5,441,401
Filed 2021-02-12 18:57
Tx date 2021-02-11
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-89,800.50
-65,500 vol
$1.37 each
5,457,001
Filed 2021-02-12 18:57
Tx date 2021-02-10
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-443,229.60
-326,000 vol
$1.36 each
5,522,501
Filed 2021-02-12 18:56
Tx date 2021-02-09
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-121,199.12
-95,200 vol
$1.27 each
5,848,501
Filed 2021-02-12 18:55
Tx date 2021-02-08
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-94,521.85
-78,500 vol
$1.20 each
5,943,701
Filed 2021-02-03 21:46
Tx date 2021-01-31
$APLI
Appili Therapeutics Inc.
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$140,000
+140,000 vol
$1.00 each
140,000
Filed 2021-02-03 21:44
Tx date 2021-01-31
$APLI
Appili Therapeutics Inc.
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-03 21:43
Tx date 2021-01-31
$APLI
Appili Therapeutics Inc.
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-03 21:41
Tx date 2021-02-01
$APLI
Appili Therapeutics Inc.
Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-29 17:32
Tx date 2021-01-27
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$14,078
+14,100 vol
$1.00 each
6,022,201
Filed 2021-01-29 17:31
Tx date 2021-01-26
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$10,043
+9,200 vol
$1.09 each
6,008,101
Filed 2021-01-22 17:24
Tx date 2021-01-20
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,352
+1,200 vol
$1.13 each
5,998,901
Filed 2021-01-15 17:04
Tx date 2021-01-15
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$30,238
+27,100 vol
$1.12 each
5,997,701
Filed 2021-01-15 17:03
Tx date 2021-01-14
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$3,626
+3,300 vol
$1.10 each
5,970,601
Filed 2021-01-15 17:03
Tx date 2021-01-13
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,996
+1,800 vol
$1.11 each
5,967,301
Filed 2021-01-08 17:50
Tx date 2021-01-06
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$3,386
+3,000 vol
$1.13 each
5,965,501
Filed 2021-01-08 17:49
Tx date 2021-01-05
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$570.00
+500 vol
$1.14 each
5,962,501
Filed 2020-12-31 17:06
Tx date 2020-12-31
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$48,776
+40,800 vol
$1.20 each
5,962,001
Filed 2020-12-31 17:05
Tx date 2020-12-30
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,950
+1,700 vol
$1.15 each
5,921,201
Filed 2020-12-31 17:04
Tx date 2020-12-29
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$5,031
+4,400 vol
$1.14 each
5,919,501
Filed 2020-12-25 10:02
Tx date 2020-12-24
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$4,669
+3,900 vol
$1.20 each
5,915,101
Filed 2020-12-25 10:02
Tx date 2020-12-23
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$3,911
+3,200 vol
$1.22 each
5,911,201
Filed 2020-12-25 10:02
Tx date 2020-12-21
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$41,828
+34,300 vol
$1.22 each
5,908,001
Filed 2020-12-18 17:42
Tx date 2020-12-18
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$116,854
+91,200 vol
$1.28 each
5,873,701
Filed 2020-12-18 17:41
Tx date 2020-12-17
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$98,266
+75,700 vol
$1.30 each
5,782,501
Filed 2020-12-18 17:41
Tx date 2020-12-16
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$24,086
+18,300 vol
$1.32 each
5,706,801
Filed 2020-12-18 17:41
Tx date 2020-12-15
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-8,071.79
-5,900 vol
$1.37 each
5,688,501
Filed 2020-12-18 17:40
Tx date 2020-12-14
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-670.00
-500 vol
$1.34 each
5,694,401
Filed 2020-12-11 17:55
Tx date 2020-12-09
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$3,820
+3,300 vol
$1.16 each
5,694,901
Filed 2020-12-10 13:55
Tx date 2020-12-07
$APLI
Appili Therapeutics Inc.
Cilla, Donald
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$244,000
+200,000 vol
$1.22 each
200,000
Filed 2020-12-10 13:53
Tx date 2020-11-01
$APLI
Appili Therapeutics Inc.
Cilla, Donald
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-11-27 17:28
Tx date 2020-11-26
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$6,530
+6,100 vol
$1.07 each
5,691,601
Filed 2020-11-27 17:27
Tx date 2020-11-25
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,938
+1,800 vol
$1.08 each
5,685,501
Filed 2020-11-27 17:27
Tx date 2020-11-24
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$8,767
+8,000 vol
$1.10 each
5,683,701
Filed 2020-11-27 17:27
Tx date 2020-11-23
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,216
+1,100 vol
$1.11 each
5,675,701
Filed 2020-11-24 12:13
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
8,491
Filed 2020-11-24 12:11
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
8,491
Filed 2020-11-24 11:05
Tx date 2020-11-20
$APLI
Appili Therapeutics Inc.
Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
54 - Exercise of warrants

-2,200 vol
537,322
Filed 2020-11-24 10:53
Tx date 2020-11-20
$APLI
Appili Therapeutics Inc.
Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
54 - Exercise of warrants

-2,200 vol
537,322
Filed 2020-11-20 17:02
Tx date 2020-11-18
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,095
+1,000 vol
$1.09 each
5,674,601
Filed 2020-11-20 17:02
Tx date 2020-11-17
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,070
+1,000 vol
$1.07 each
5,673,601
Filed 2020-11-20 17:02
Tx date 2020-11-16
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$4,708
+4,300 vol
$1.10 each
5,672,601
Filed 2020-11-13 16:48
Tx date 2020-11-09
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$4,988
+4,300 vol
$1.16 each
5,668,301
Filed 2020-11-06 16:58
Tx date 2020-11-06
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-29,231.76
-18,600 vol
$1.57 each
5,664,001
Filed 2020-10-30 16:58
Tx date 2020-10-30
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-34,913.67
-24,100 vol
$1.45 each
5,682,601
Filed 2020-10-30 16:57
Tx date 2020-10-29
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-4,006.93
-2,900 vol
$1.38 each
5,706,701
Filed 2020-10-23 16:41
Tx date 2020-10-23
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$2,041
+1,500 vol
$1.36 each
5,709,601
Filed 2020-10-23 16:40
Tx date 2020-10-22
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$7,506
+5,500 vol
$1.36 each
5,708,101
Filed 2020-10-09 16:37
Tx date 2020-10-05
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-14,107.28
-9,200 vol
$1.53 each
5,702,601
Filed 2020-10-02 16:58
Tx date 2020-10-02
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-6,565.05
-4,500 vol
$1.46 each
5,711,801
Filed 2020-10-02 16:58
Tx date 2020-10-01
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-75,492.34
-53,900 vol
$1.40 each
5,716,301
Filed 2020-10-02 16:57
Tx date 2020-09-30
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-8,151
-6,000 vol
$1.36 each
5,770,201
Filed 2020-09-25 16:58
Tx date 2020-09-25
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-55,623.75
-45,500 vol
$1.22 each
5,776,201
Filed 2020-09-25 16:57
Tx date 2020-09-22
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-2,400
-2,000 vol
$1.20 each
5,821,701
Filed 2020-09-18 19:54
Tx date 2020-09-16
$APLI
Appili Therapeutics Inc.
Golan, Yoav
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$218,000
+200,000 vol
$1.09 each
200,000
Filed 2020-09-18 19:53
Tx date 2020-04-01
$APLI
Appili Therapeutics Inc.
Golan, Yoav
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-18 19:48
Tx date 2020-09-16
$APLI
Appili Therapeutics Inc.
Balboni, Armand
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
1,218,000
Filed 2020-09-18 19:45
Tx date 2020-09-16
$APLI
Appili Therapeutics Inc.
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$152,600
+140,000 vol
$1.09 each
280,000
Filed 2020-09-18 19:43
Tx date 2020-09-16
$APLI
Appili Therapeutics Inc.
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$152,600
+140,000 vol
$1.09 each
325,000
Filed 2020-09-18 19:41
Tx date 2020-09-16
$APLI
Appili Therapeutics Inc.
Mortimer, Ian Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$152,600
+140,000 vol
$1.09 each
325,000
Filed 2020-09-18 19:34
Tx date 2020-09-16
$APLI
Appili Therapeutics Inc.
Stephens, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$109,000
+100,000 vol
$1.09 each
410,000
Filed 2020-09-18 17:01
Tx date 2020-09-18
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-595.00
-500 vol
$1.19 each
5,823,701
Filed 2020-08-28 16:59
Tx date 2020-08-28
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$6,155
+8,000 vol
$0.77 each
5,824,201
Filed 2020-08-28 16:59
Tx date 2020-08-24
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$59,255
+69,500 vol
$0.85 each
5,816,201
Filed 2020-08-23 19:24
Tx date 2020-08-21
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$27,054
+29,500 vol
$0.92 each
5,746,701
Filed 2020-08-07 17:14
Tx date 2020-08-04
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$10,940
+12,000 vol
$0.91 each
5,717,201
Filed 2020-08-01 10:29
Tx date 2020-07-31
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$7,910
+8,500 vol
$0.93 each
5,705,201
Filed 2020-08-01 10:28
Tx date 2020-07-29
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,380
+1,500 vol
$0.92 each
5,696,701
Filed 2020-07-24 17:08
Tx date 2020-07-24
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,459
+1,500 vol
$0.97 each
5,695,201
Filed 2020-07-24 17:07
Tx date 2020-07-23
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$24,025
+24,300 vol
$0.99 each
5,693,701
Filed 2020-07-24 17:07
Tx date 2020-07-21
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$30,142
+31,200 vol
$0.97 each
5,669,401
Filed 2020-07-24 17:06
Tx date 2020-07-20
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$16,683
+16,300 vol
$1.02 each
5,638,201
Filed 2020-07-17 17:01
Tx date 2020-07-17
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$948.96
+900 vol
$1.05 each
5,621,901
Filed 2020-07-17 17:01
Tx date 2020-07-16
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$5,406
+5,100 vol
$1.06 each
5,621,001
Filed 2020-07-03 19:57
Tx date 2020-06-30
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$455.00
+500 vol
$0.91 each
5,615,901
Filed 2020-06-12 17:41
Tx date 2020-06-10
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus

+692,642 vol
2,020,142
Filed 2020-06-12 17:33
Tx date 2020-06-10
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
15 - Acquisition or disposition under a prospectus
$1,662,340
+1,385,284 vol
$1.20 each
5,615,401
Filed 2020-06-12 17:31
Tx date 2020-06-04
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$28,577
+25,000 vol
$1.14 each
4,230,117
Filed 2020-06-10 12:04
Tx date 2020-06-10
$APLI
Appili Therapeutics Inc.
Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
15 - Acquisition or disposition under a prospectus

+280,777 vol
539,522
Filed 2020-06-10 11:55
Tx date 2020-06-10
$APLI
Appili Therapeutics Inc.
Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
15 - Acquisition or disposition under a prospectus

+280,777 vol
539,522
Filed 2020-05-29 17:02
Tx date 2020-05-29
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$4,285
+2,800 vol
$1.53 each
4,205,117
Filed 2020-05-29 17:02
Tx date 2020-05-28
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,856
+1,200 vol
$1.55 each
4,202,317
Filed 2020-05-29 17:01
Tx date 2020-05-27
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$72,763
+47,200 vol
$1.54 each
4,201,117
Filed 2020-05-29 17:01
Tx date 2020-05-26
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$3,510
+2,200 vol
$1.60 each
4,153,917
Filed 2020-05-22 17:04
Tx date 2020-05-21
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,849
+1,200 vol
$1.54 each
4,151,717
Filed 2020-05-15 17:03
Tx date 2020-05-11
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$34,696
+24,000 vol
$1.45 each
4,150,517
Filed 2020-05-08 17:47
Tx date 2020-05-08
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$14,116
+9,600 vol
$1.47 each
4,126,517
Filed 2020-05-08 17:47
Tx date 2020-05-07
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$18,577
+12,400 vol
$1.50 each
4,116,917
Filed 2020-05-08 17:46
Tx date 2020-05-05
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$6,000
+4,000 vol
$1.50 each
4,104,517
Filed 2020-05-02 16:19
Tx date 2020-04-30
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$51,867
+35,800 vol
$1.45 each
4,100,517
Filed 2020-05-02 16:18
Tx date 2020-04-29
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-9,018
-6,000 vol
$1.50 each
4,064,717
Filed 2020-05-02 16:18
Tx date 2020-04-28
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-21,270.24
-14,400 vol
$1.48 each
4,070,717
Filed 2020-04-20 18:26
Tx date 2020-04-17
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-315.00
-300 vol
$1.05 each
4,085,117
Filed 2020-04-20 18:26
Tx date 2020-04-16
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-3,385.92
-3,200 vol
$1.06 each
4,085,417
Filed 2020-04-20 18:25
Tx date 2020-04-14
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-2,535
-2,500 vol
$1.01 each
4,088,617
Filed 2020-04-13 17:12
Tx date 2020-04-09
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$3,360
+3,500 vol
$0.96 each
4,091,117
Filed 2020-04-03 17:17
Tx date 2020-04-03
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-8,670
-10,000 vol
$0.87 each
4,087,617
Filed 2020-04-03 17:17
Tx date 2020-03-31
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-6,800
-10,000 vol
$0.68 each
4,097,617
Filed 2020-03-27 16:59
Tx date 2020-03-25
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-20,484.80
-28,000 vol
$0.73 each
4,107,617
Filed 2020-03-21 13:22
Tx date 2020-03-20
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-670.00
-1,000 vol
$0.67 each
4,135,617
Filed 2020-03-21 13:21
Tx date 2020-03-19
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-2,970
-4,500 vol
$0.66 each
4,136,617
Filed 2020-03-16 17:20
Tx date 2020-03-13
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$35,091
+63,000 vol
$0.56 each
4,141,117
Filed 2020-03-16 17:20
Tx date 2020-03-12
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$27,189
+44,500 vol
$0.61 each
4,078,117
Filed 2020-03-16 17:19
Tx date 2020-03-11
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-6,237
-9,000 vol
$0.69 each
4,033,617
Filed 2020-03-16 17:19
Tx date 2020-03-11
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$68,250
+105,000 vol
$0.65 each
4,042,617
Filed 2020-03-16 17:17
Tx date 2020-03-10
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$-1,400
-2,000 vol
$0.70 each
3,937,617
Filed 2020-03-02 16:46
Tx date 2020-02-28
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$21,804
+31,500 vol
$0.69 each
3,939,617
Filed 2020-03-02 16:45
Tx date 2020-02-26
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$5,950
+8,500 vol
$0.70 each
3,908,117
Filed 2020-03-02 16:45
Tx date 2020-02-25
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$3,449
+5,000 vol
$0.69 each
3,899,617
Filed 2020-03-02 16:44
Tx date 2020-02-24
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market
$1,900
+2,500 vol
$0.76 each
3,894,617
Filed 2020-02-22 14:37
Tx date 2020-02-20
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
1,327,500
Filed 2020-02-22 14:36
Tx date 2020-02-20
$APLI
Appili Therapeutics Inc.
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
3,892,117
Filed 2020-02-20 12:16
Tx date 2020-02-20
$APLI
Appili Therapeutics Inc.
Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
15 - Acquisition or disposition under a prospectus

+256,545 vol
258,745
Filed 2020-02-20 11:50
Tx date 2020-02-20
$APLI
Appili Therapeutics Inc.
Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
15 - Acquisition or disposition under a prospectus

+256,545 vol
258,745
Filed 2020-02-05 15:59
Tx date 2020-01-24
$APLI
Appili Therapeutics Inc.
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$114,099
+140,000 vol
$0.81 each
140,000
Filed 2020-02-05 15:55
Tx date 2020-01-24
$APLI
Appili Therapeutics Inc.
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-06 13:33
Tx date 2019-12-02
$APLI
Appili Therapeutics Inc.
Balboni, Armand
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,000,000 vol
1,018,000
Filed 2019-12-06 10:46
Tx date 2019-12-02
$APLI
Appili Therapeutics Inc.
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$77,000
+140,000 vol
$0.55 each
185,000
Filed 2019-12-06 10:44
Tx date 2019-12-02
$APLI
Appili Therapeutics Inc.
Mortimer, Ian Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$77,000
+140,000 vol
$0.55 each
185,000
Filed 2019-12-06 10:41
Tx date 2019-12-02
$APLI
Appili Therapeutics Inc.
Stephens, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$110,000
+200,000 vol
$0.55 each
310,000
Filed 2019-06-22 16:04
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton & Co. Inc. (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
14,350,120
Filed 2019-06-22 16:01
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
2,200
Filed 2019-06-22 15:51
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton & Co. Inc. (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
2,200
Filed 2019-06-22 15:47
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
14,350,120
Filed 2019-06-18 15:22
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Development Corporation (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-18 15:12
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Development Corporation (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-21 13:59
Tx date 2017-01-01
$APLI
Appili Therapeutics Inc.
Nicolle, Stephen
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
45,000
Filed 2019-06-21 13:55
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
45,000
Filed 2019-06-20 14:23
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Balboni, Armand
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
18,000
Filed 2019-06-20 10:43
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Stephens, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
110,000
Filed 2019-06-20 10:42
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Stephens, Kimberly
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
57,436
Filed 2019-06-20 10:34
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Sullivan, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
355,000
Filed 2019-06-20 10:33
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Sullivan, Kevin
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
14,243
Filed 2019-06-20 10:32
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Sullivan, Kevin
5 - Senior Officer of Issuer
Holder: Crimson Research Inc. (Indirect Ownership)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
772,000
Filed 2019-06-19 12:33
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Mortimer, Ian Charles
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
45,000
Filed 2019-06-18 15:22
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Development Corporation (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
13,896,000
Filed 2019-06-18 15:12
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Development Corporation (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
13,896,000
Filed 2019-06-18 15:01
Tx date 2019-06-13
$APLI
Appili Therapeutics Inc.
Bloom Burton Development Corporation
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
13,896,000